Erin Michelle O'Brien, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perylene | 4 | 2010 | 22 | 1.070 |
Why?
|
| Quinones | 4 | 2010 | 79 | 1.060 |
Why?
|
| Interleukin-4 | 1 | 2021 | 1156 | 0.570 |
Why?
|
| Prostheses and Implants | 1 | 2019 | 1275 | 0.400 |
Why?
|
| Affect | 2 | 2011 | 1494 | 0.380 |
Why?
|
| Pain | 4 | 2011 | 5101 | 0.370 |
Why?
|
| Aldehydes | 1 | 2010 | 170 | 0.310 |
Why?
|
| Macrophages | 3 | 2022 | 5785 | 0.310 |
Why?
|
| Ketones | 1 | 2010 | 183 | 0.310 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3582 | 0.310 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2212 | 0.290 |
Why?
|
| Actigraphy | 1 | 2011 | 527 | 0.280 |
Why?
|
| Stereoisomerism | 5 | 2010 | 612 | 0.260 |
Why?
|
| Phenol | 3 | 2010 | 45 | 0.240 |
Why?
|
| Biological Products | 2 | 2010 | 948 | 0.220 |
Why?
|
| Photosensitizing Agents | 1 | 2008 | 627 | 0.210 |
Why?
|
| Awareness | 1 | 2007 | 653 | 0.210 |
Why?
|
| Cyclodextrins | 1 | 2022 | 63 | 0.200 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 101 | 0.200 |
Why?
|
| Catalysis | 5 | 2010 | 766 | 0.190 |
Why?
|
| Circadian Rhythm | 2 | 2011 | 2591 | 0.190 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2011 | 1107 | 0.190 |
Why?
|
| Cyclization | 2 | 2010 | 59 | 0.170 |
Why?
|
| Pain Clinics | 2 | 2010 | 50 | 0.170 |
Why?
|
| Interleukin-15 Receptor alpha Subunit | 1 | 2019 | 2 | 0.170 |
Why?
|
| Spinal Nerve Roots | 1 | 2000 | 122 | 0.170 |
Why?
|
| Risk-Taking | 1 | 2005 | 1023 | 0.160 |
Why?
|
| Molecular Structure | 4 | 2010 | 1882 | 0.150 |
Why?
|
| Interleukin-15 | 1 | 2019 | 186 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2007 | 2023 | 0.150 |
Why?
|
| Emotions | 1 | 2010 | 2760 | 0.150 |
Why?
|
| Steroids | 1 | 2003 | 937 | 0.140 |
Why?
|
| Hydrogels | 1 | 2022 | 729 | 0.140 |
Why?
|
| Pain Measurement | 3 | 2011 | 3584 | 0.130 |
Why?
|
| Sleep | 1 | 2011 | 4816 | 0.120 |
Why?
|
| Chronic Disease | 4 | 2011 | 9362 | 0.120 |
Why?
|
| Nerve Block | 1 | 2000 | 717 | 0.100 |
Why?
|
| Phenotype | 2 | 2021 | 16718 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2598 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2350 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2000 | 1811 | 0.100 |
Why?
|
| Depression | 1 | 2011 | 8234 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2011 | 6023 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 2209 | 0.080 |
Why?
|
| Contrast Media | 1 | 2003 | 5329 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2010 | 6331 | 0.080 |
Why?
|
| Naphthalenes | 1 | 2010 | 198 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 13650 | 0.080 |
Why?
|
| Disulfides | 1 | 2010 | 462 | 0.070 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2007 | 23 | 0.070 |
Why?
|
| Sulfones | 1 | 2010 | 447 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2008 | 540 | 0.070 |
Why?
|
| Back Pain | 1 | 2009 | 547 | 0.060 |
Why?
|
| Fibromyalgia | 1 | 2009 | 407 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3431 | 0.060 |
Why?
|
| Pennsylvania | 1 | 2005 | 615 | 0.050 |
Why?
|
| Phosphines | 1 | 2003 | 18 | 0.050 |
Why?
|
| Periodicity | 1 | 2005 | 347 | 0.050 |
Why?
|
| Employment | 1 | 2009 | 1110 | 0.050 |
Why?
|
| Fatigue | 1 | 2009 | 1556 | 0.050 |
Why?
|
| Leukemia | 1 | 2010 | 1518 | 0.050 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2005 | 279 | 0.050 |
Why?
|
| Injections, Epidural | 1 | 2003 | 203 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6215 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 2429 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10869 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2022 | 965 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2022 | 2275 | 0.040 |
Why?
|
| Humans | 12 | 2022 | 767040 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2003 | 948 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2019 | 276 | 0.040 |
Why?
|
| Neck | 1 | 2003 | 736 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2005 | 848 | 0.040 |
Why?
|
| Adult | 5 | 2011 | 223317 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2003 | 2276 | 0.040 |
Why?
|
| Wakefulness | 1 | 2005 | 1282 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2011 | 6260 | 0.040 |
Why?
|
| Female | 7 | 2011 | 396660 | 0.040 |
Why?
|
| Educational Status | 1 | 2005 | 2511 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2003 | 1110 | 0.030 |
Why?
|
| Age Distribution | 1 | 2003 | 2870 | 0.030 |
Why?
|
| Imidazoles | 1 | 2003 | 1169 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2007 | 2647 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 2662 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14672 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 7848 | 0.030 |
Why?
|
| Sex Factors | 1 | 2009 | 10622 | 0.030 |
Why?
|
| Polymers | 1 | 2022 | 1624 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2010 | 5098 | 0.030 |
Why?
|
| Male | 6 | 2011 | 364203 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9464 | 0.030 |
Why?
|
| Health Surveys | 1 | 2005 | 4056 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2010 | 3052 | 0.030 |
Why?
|
| Apoptosis | 1 | 2010 | 9513 | 0.030 |
Why?
|
| Middle Aged | 4 | 2011 | 223233 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2009 | 4526 | 0.030 |
Why?
|
| Animals | 3 | 2022 | 168965 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 15925 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3608 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 22350 | 0.020 |
Why?
|
| Comorbidity | 1 | 2005 | 10582 | 0.020 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2010 | 112 | 0.020 |
Why?
|
| Cognition | 1 | 2007 | 7059 | 0.020 |
Why?
|
| Adolescent | 2 | 2010 | 89046 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5499 | 0.020 |
Why?
|
| Decarboxylation | 1 | 2007 | 8 | 0.020 |
Why?
|
| Palladium | 1 | 2007 | 67 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2010 | 658 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7587 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15424 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3944 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 3114 | 0.020 |
Why?
|
| Incidence | 1 | 2003 | 21526 | 0.010 |
Why?
|
| Aged | 2 | 2010 | 171319 | 0.010 |
Why?
|
| Mice | 2 | 2022 | 81912 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2221 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 26325 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 59980 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 65295 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2927 | 0.010 |
Why?
|
| Electrons | 1 | 2003 | 264 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6014 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5389 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2009 | 81659 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18330 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2010 | 5388 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5796 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 54886 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 59548 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 3273 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 12793 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10455 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9532 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 17097 | 0.010 |
Why?
|